Bagsværd, Denmark, 21 May 2021 - Novo Nordisk A/S today
announced that Novo Nordisk has established a Euro Medium Term Note
(EMTN) programme. The programme provides a framework for Novo Nordisk
to complete issuances of senior unsecured notes up to an aggregated
total amount of EUR 5 billion. The details of the programme are
outlined below:
Issuer: | | Novo Nordisk A/S or
Novo Nordisk Finance (Netherlands) B.V. |
Guarantor: | | Novo Nordisk
A/S |
Programme size: | | EUR 5,000,000,000 |
Arranger: | | Citigroup
|
Dealers: | | Citigroup, Danske
Bank, Deutsche Bank, Handelsbanken Capital Markets, HSBC, ING,
J.P. Morgan, MUFG, Morgan Stanley, Nordea, Nykredit Bank A/S,
SEB |
Prospectus: | | EUR
5,000,000,000 EMTN Programme dated 20 May 2021 |
Read the press
release
Read
the prospectus